Literature DB >> 21134111

Validation of a Mayo post-operative mortality risk prediction model in Korean cirrhotic patients.

Seung Young Kim1, Hyung Joon Yim, Seon Min Park, Jeong Han Kim, Sung Woo Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Hong Sik Lee, Sang Woo Lee, Soon Ho Um, Kwan Soo Byun, Jai Hyun Choi, Ho Sang Ryu.   

Abstract

BACKGROUND: Patients with cirrhosis have an increased risk of mortality after surgery. In 2007, a new model was suggested to calculate mortality risk at specific time points after surgery at the Mayo clinic. AIMS: We investigated the mortality risks in Korean cirrhotic patients who underwent various surgeries and applied the Mayo clinic model to our study populations.
METHODS: We conducted a retrospective review of the charts of 160 patients with cirrhosis who underwent surgical procedures under general anaesthesia between January 1996 and December 2006 at two hospitals.
RESULTS: The overall 30-, 90-day and 1-year mortality rates were 7.5, 9.4 and 10.6% respectively. In multivariate analysis, the Child-Turcotte-Pugh (CTP) score, model for end-stage liver disease (MELD) and the American Society of Anesthesiologists (ASA) physical status classification and age were significantly associated with mortality. The area under the receiver operating characteristic (AUROC) from the calculated value using Mayo model as a predictor of 30-, 90-day and 1-year mortality was 0.832, 0.803 and 0.822 respectively, of which, 1-year mortality was significantly different from AUROC of mortality prediction based on our patient's data (P=0.025). In addition, the mean of predicted 1-year mortality rate (22.6±12.0%) using Mayo model was significantly higher than that from observed (8.9±1.4%, P<0.01).
CONCLUSIONS: The CTP score or MELD score or ASA physical class and age were found to be significant predictors of post-operative mortality in cirrhotic patients. The risk prediction model developed at the Mayo clinic showed good performance in Korean cirrhotic patients. However, we found that the model tended to overestimate mortality, especially 1 year after surgery.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134111     DOI: 10.1111/j.1478-3231.2010.02419.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  6 in total

Review 1.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

2.  In-Hospital mortality varies by procedure type among cirrhosis surgery admissions.

Authors:  Nadim Mahmud; Zachary Fricker; Marina Serper; David E Kaplan; Kenneth D Rothstein; David S Goldberg
Journal:  Liver Int       Date:  2019-06-17       Impact factor: 5.828

3.  External Validation of the VOCAL-Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems.

Authors:  Nadim Mahmud; Zachary Fricker; Sarjukumar Panchal; James D Lewis; David S Goldberg; David E Kaplan
Journal:  Liver Transpl       Date:  2021-07       Impact factor: 6.112

4.  Trends in surgical volume and in-hospital mortality among United States cirrhosis hospitalizations.

Authors:  Kristen M Tessiatore; Nadim Mahmud
Journal:  Ann Gastroenterol       Date:  2020-11-20

5.  The emotional burden of caregiving for patients with cirrhosis.

Authors:  Zachary M Saleh; Najat E Salim; Samantha Nikirk; Marina Serper; Elliot B Tapper
Journal:  Hepatol Commun       Date:  2022-07-06

6.  Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis.

Authors:  Nadim Mahmud; Zachary Fricker; Rebecca A Hubbard; George N Ioannou; James D Lewis; Tamar H Taddei; Kenneth D Rothstein; Marina Serper; David S Goldberg; David E Kaplan
Journal:  Hepatology       Date:  2020-12-10       Impact factor: 17.425

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.